Portage biotech reports results for fiscal quarter ended june 30, 2023, and business update

Westport, conn., nov. 28, 2023 (globe newswire) -- portage biotech inc. (nasdaq: prtg), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported financial results for the fiscal quarter ended september 30, 2023.
ATON Ratings Summary
ATON Quant Ranking